Considering that PBMCs contain many different immune cells and that myeloid cell lineage macrophages are crucial in vivo targets in patients with HIV-1 infection, we next treated primary monocyte-derived macrophages (MDMs) and monocyte-derived dendritic cells (MDDCs) with IFN-α for different periods. This evidence concerns the gene IFNA2 and HIV-1 infection.